The largest database of trusted experimental protocols

Thrombopoietin tpo

Manufactured by Thermo Fisher Scientific
Sourced in United States, Canada

Thrombopoietin (TPO) is a glycoprotein hormone that plays a crucial role in the regulation of platelet production. It is responsible for stimulating the proliferation and differentiation of megakaryocytes, which are the precursor cells that give rise to platelets. TPO is an essential component in the maintenance of normal platelet levels and the management of various hematological conditions.

Automatically generated - may contain errors

33 protocols using thrombopoietin tpo

1

CRISPR-Cas9 gene editing in HL60 and HSPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cas9 was expressed in HL60 cells, kindly provided by Associate Prof. Mattias Magnusson, through transduction of a modified version of the pLCv2 vector containing a Cas9-P2A-BFP cassette. Transduced cells were then selected based on fluorescent marker expression. The Cas9-expressing HL60 cells were cultured in HyClone RPMI-1640 Medium (Cytiva) supplemented with 10% heat-inactivated FBS (Cytiva) and 1% Penicillin–Streptomycin (Cytiva). Primary CD34+ HSPCs were thawed and cultured in Serum-Free Expansion Medium (SFEM, Stem Cell Technologies) complemented with 1% Penicillin–Streptomycin (Cytiva) and Stem cell factor (SCF), FLT3-ligand (FLT3L) and thrombopoietin (TPO) were added in the concentration 100 ng/ml and acquired from PeproTech or Miltenyi Biotec. The CD34+ cells were cultured at 37 °C, 5% CO2 for 24 h prior to lentiviral transduction and 48 h prior to RNP electroporation.
+ Open protocol
+ Expand
2

Expansion and Isolation of UCB Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gelofusine and EasySep™ treated UCB cells were cultured for 10 to 12 days in StemSpan™ ACF medium (STEMCELL Technologies) supplemented with growth factors, Stem Cell Factor (SCF; 100 ng/ml, R&D Systems), Flt3 ligand (FLT3-L; 100 ng/ml, R&D Systems) and Thrombopoietin (TPO; 20 ng/ml, PEPROTECH). When indicated, UM171 (35 μM, STEMCELLS Technologies) and/or SR1 (500 μM, STEMCELLS Technologies) were added. Viable Lin-CD34+CD45-CD133+, Lin-CD34+CD45-CXCR4+ or Lin-CD34+CD45− NANOG+ cells were then sorted and quantified.
+ Open protocol
+ Expand
3

Pot1a Overexpression in Hematopoietic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Freshly isolated LSK, LSKFlt3 cells or LSKCD41CD48CD150+ cells were pre-cultured for 1 day in SF-O3 medium (EIDIA Co., Ltd.) in the presence of 0.1% BSA, 100 ng ml−1 stem cell factor (SCF) (PeproTech), and 100 ng ml−1 thrombopoietin (TPO) (PeproTech), and then transfected with retrovirus-expressing Pot1a or shPot1a on RetroNectin™ (Takara Bio Inc.) using MagnetofectionTM (OZ Biosciences) according to the manufacturer’s instructions. The cells were then cultured for one day at 37 °C in 5% CO2. The efficiency of Pot1a overexpression or suppression in HSCs was confirmed by Q-PCR.
+ Open protocol
+ Expand
4

Transduction of CD34+ Cells for WAS Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patients’ bone marrow cells harvested under general anesthesia, were separated with lymphoprep (Eurobio, Oslo, Norway) and centrifuged in order to collect mononuclear cells (MNC). Patient’s MPB was collected by apheresis. The positive selection of CD34+ cells from MNC or from MPB was performed using immunomagnetic beads and an immunomagnetic enrichment device (CliniMACs, Miltenyi Biotec, Bergish – Gladbach, Germany). Purified CD34+ cells were seeded on cell culture bags pre-coated with clinical grade Retronectin™ (Takara Bio Co) in serum free medium (X-Vivo 20, Biowhittacker/Lonza) and clinical grade stem cell factor (SCF) (300 ng/ml), FLT3-L (300 ng/ml), thrombopoietin (TPO) (100 ng/ml) and IL-3 (20 ng/ml) (all from Peprotech). After 24 hours of prestimulation, cells were transduced twice with LV-w1.6.WASp (1×108ig/ml) each time for 18 hours. At the end of the transduction procedure, washed cells were resuspended in 4% human serum albumin and transferred in a sterile bag for infusion to the patient. Aliquots of cells were further cultured for 14 days to measure stable proviral integration by qPCR and WASp expression by flow cytometry.
+ Open protocol
+ Expand
5

Optimized Expansion of UCB-Derived CD34+ Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each expansion, a fraction of the pool of UCB-derived CD34+-enriched cells was thawed and seeded at a density of 30,000 cells/mL, both with the presence of an MSC(AT) feeder layer (co-culture) and without (no feeder layer control [No FL]). HSPC were expanded for 7 days in StemSpan Serum-Free Expansion Medium (SFEM) II (STEMCELL Technologies, Vancouver, BC, Canada) (2 mL/well) supplemented with 1% (v/v) A/A and a cytokine cocktail consisting of stem cell factor (SCF), fms-like tyrosine kinase 3 ligand (Flt-3L), thrombopoietin (TPO), and basic fibroblast growth factor (bFGF) (PeproTech, Cranbury, NJ, USA) with concentrations of 90, 77, 82, and 5 ng/mL, respectively. The cytokine concentrations that were used were previously optimized by our group targeting maximization of the expansion of UCB-derived CD34+-enriched cells in co-culture with MSC [27 (link)].
+ Open protocol
+ Expand
6

Murine acute myeloid leukemia model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow cells were isolated from femurs and tibias of Per2::Luc knock-in mice by flushing with PBS. Freshly isolated LSK CD48CD150+ cells were sorted with a fluorescence-activated cell sorter FACSAria (BD Biosciences) and precultured for 1 day in SF-O3 medium (EIDIA) containing stem cell factor (SCF; 100 ng/ml) (PeproTech) and thrombopoietin (TPO; 100 ng/ml) (PeproTech). The cells were then infected with MLL-AF9–expressing retroviral particles using the Magnetofection technology (OZ Biosciences). After 2 days of infection, green fluorescent protein (GFP)–positive cells were sorted into single cells using FACSAria and cultured for at least six passages to leukemic granulocyte/megakaryocytes progenitor clones. The leukemia cells were subjected to retro-orbital transplantation (0.5 × 106 to 1.0 × 106 cells per mouse) into sublethally irradiated (6 Gy) C57BL/6 J mice to develop AML. Serial transplantations of the leukemia cells caused AML in nonirradiated recipients, which were used for experiments. As controls for the circadian assay, bone marrow cells from Per2::Luc knock-in mice were transplanted into C57BL/6 J mice and used 3 months after transplantation.
+ Open protocol
+ Expand
7

K562 Cell Culture and CD34+ Cell Pretreatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
K562 cells were cultured in RPMI medium + 10% heat-inactivated fetal bovine serum [HI FBS (Gibco/ThermoFisher; Waltham, MA)] + 1% penicillin, streptomycin, glutamine [PSQ (Gemini Bio-Products; Sacramento, CA)], and were kept at a density between 1 × 105 and 1 × 106 cells per ml. Healthy human CD34+ cells from mPB (peripheral blood stem cells, PBSCs) were thawed in pre-warmed X-Vivo 15 medium (Lonza; Basel, Switzerland) with 1% PSQ, pelleted at 500×g for 5 min, and resuspended at 5 × 105 cells/mL in pre-warmed X-Vivo 15 medium with PSQ and SFT cytokines [50 ng/mL stem cell factor (SCF), 50 ng/mL fms-related tyrosine kinase 3 ligand (Flt3-L), and 50 ng/mL thrombopoietin (TPO)] (Peprotech; Rocky Hill, NJ). Cells were pre-stimulated at 37°C and 5% CO2 incubator for 48 h.
+ Open protocol
+ Expand
8

Erythroid Expansion from Differentiated Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples from the end of Step 1 were collected and incubated with a medium for erythroid specification and expansion. Two different recombinant factor cocktails were tested using complete StemPro34 (SP34) (Thermo Fisher Scientific) as basal media: (i) SP34 supplemented with four factors (SP34+4F): holo-transferrin (500 µg/mL; R&D Systems, Minneapolis, MN, USA), SCF (50 ng/mL), EPO (2 U/mL), and IL-3 (10 ng/m); and (ii) SP34 supplemented with six factors (SP34+6F): SCF (50 ng/mL), VEGF (50 ng/mL), IL-6 (30 ng/mL), IL-3 (30 ng/mL), thrombopoietin (TPO) (30 ng/mL/mL) (PeproTech), and EPO (3 U/mL). Both media were supplemented with 1% penicillin/streptomycin solution. SP34+4F medium was used only for cells in suspension. SP34+6F medium was adapted from the protocol of Ng et al. [34 (link)] and used for the adherent culture of EBs in 24-well plates coated with Geltrex. Under all conditions, the medium was changed every 3–4 days until D26, when the cells in the supernatant were collected for analysis.
+ Open protocol
+ Expand
9

Investigating Molecular Signaling in Myeloproliferative Neoplasms

Check if the same lab product or an alternative is used in the 5 most similar protocols
We collected MPN patient bone marrow specimens from the Stanford Cancer Center, and whole blood from healthy donors at the Stanford Blood Center. Cell culture supplies including plates, fetal bovine serum, penicillin, streptomycin, phosphate-buffered saline (PBS), and culture medium were procured from GIBCO BRL (Frederick, MD). Antibodies for CALR, CDC20, p-PI3K, p-Akt, b-Actin and anti-rabbit goat IgG were procured from Cell Signaling Technologies (Danvers, MA), for enkurin from Sigma Aldrich (St. Louis, MO) and CREB3L1 from Thermo Scientific (Rockford, IL). Antibodies for Alexa647-tagged CD41, PE-CD42b, PE-CD61, and PE-CD45 were from BioLegend (San Diego, CA). shRNA for ENKUR silencing were synthesized from Protein and Nucleic acid facility at Stanford University (Stanford, CA). The human HEK 293 FT cells and THP1 human macrophage cells were purchased from the American Type Culture Collection (ATCC, Manassas, VA) and cultured following supplier instructions. The CD34, CD45 microbeads, LS and MS columns and magnetic separators were purchased from Miltenyi Biotech (Cambridge, MA). Cytokines IL6, thrombopoietin TPO, and Flt3 ligand were from PeproTech Inc. (Cranbury, NJ); SCF and SFEM II media was from Stem Cell Technologies (Kent, WA). Lenti-X GoStix Plus was purchased from TaKaRa Bio Inc. (San Jose, CA).
+ Open protocol
+ Expand
10

Erythroid Differentiation of CD34+ Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified human CD34+ progenitor cells were derived from GCSF–treated peripheral blood cells of healthy donors. These cells were grown at 37°C with 5% CO2 in serum-free medium consisting of Iscove’s modified Dulbecco’s medium (IMDM) with 1-thioglycerol, BIT9500 supplement (BITS) (Stem Cell Technologies), BSA (Sigma-Aldrich), and the indicated cytokines (PeproTech). The cells initially underwent 72 h of expansion with 100 ng/ml SCF (PeproTech), 100 ng/ml FMS-like tyrosine kinase 3 ligand (FLT3 ligand) (PeproTech), 100 ng/ml thrombopoietin (TPO) (PeproTech), and 50 ng/ml IL-3 (PeproTech). After expansion cells were then seeded in erythroid differentiation medium, which contains recombinant human erythropoietin at 4.5 U/ml (Procrit; Amgen), 10 ng/ml SCF and BIT9500 supplement. Human bronchial epithelial cells (Beas2B) were grown at 37°C with 5% CO2 in DMEM medium with 10% FBS. Horseradish peroxidase-conjugated goat anti-rabbit and anti-mouse antibodies, reverse transcriptase, and real-time PCR SosoFast reagents were purchased from Bio-Rad Laboratories (Hercules, CA). Amicon Ultra centrifuge filters were purchased from EMD Millipore (Billerica, MA). Anti-IL-33 antibody was from R&D Systems (Minneapolis, MN). Anti-LarminA/C antibody was from Santa Cruz (Dallas, TX). Anti-GAPDH and β-actin antibodies and RBC lysis buffer were from Sigma (St. Louis, MO).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!